WHO and UNICEF data show promising signs of immunisation rebounding in some countries
New WHO and UNICEF data show promising signs of immunisation services rebounding in some countries, but, particularly in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
USFDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies
The companies plan to make Beyfortus available in the United States ahead of the upcoming RSV season, Sanofi said, adding that it…
Novartis acquires DTx Pharma
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…
BridgeBio Pharma’s heart disease drug meets main goal in late-stage study
The company said no safety concerns were identified in patients, adding that it intends t submit marketing applications to the US…
Zeon Lifesciences launches liquid-filled capsules
Zeon has partnered with collaborative third-party manufacturing for liquid filled capsules
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer…
Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…
Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Atrial fibrillation market to decline during 2022-32: GlobalData
GlobalData’s report, “Atrial Fibrillation: Eight Market Drug Forecast and Market Analysis,” reveals that five late-stage pipeline…
EMA accepts Intas Pharma’s MAA for DMB-3115
herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III
Nutrizoe raises Rs 3 Cr in bridge round
The funds will be utiliaed for expanding the Lactobite portfolio after conducting clinical trials, exploring export opportunities…
DCO(I) WA’s 1st annual congress concludes successfully
The interactive sessions provided valuable insights and opportunities for skill development
SII’s MenFive receives WHO prequalification
MenFive is currently undergoing an additional Phase 3 study in healthy children between 9 and 15 months of age in Mali, to examine…
GenAI has potential to address high cost in pharma: GlobalData
GenAI is set to revolutionise drug discovery by generating novel drug candidates based on researcher-provided criteria and…
Asahi Kasei’s headquarters established in US
The Primary Executive Officer for Healthcare and staff will be located in existing Asahi Kasei offices in Chelmsford,…
Glenmark Pharma hosts drug discovery workshop for Sion Hospital students
The tour was aimed at encouraging medical students to explore new horizons in their academic journey
Merck announces 3rd edition of Merck Young Scientist Award 2023
Ten individuals will be awarded prizes totalling Rs 2,250,000
DKMS honors Professor Carl June for his work in cancer immunology
June is the Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, and Director of the…
Indoco gets EU GMP certification from German Health Authority for Goa facility
The EU certification will support supplies of drug products registered in Europe and other regions from this manufacturing site
Lupin gets EIR from US FDA for Pithampur Unit-2 facility
The EIR was issued post the last inspection of the facility conducted from March 21-29, 2023
Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis
Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement